AllQuantitative Report
logoArgusMay 05, 2021

LMAT: Lowering target price to $56.00

Symbols
LMAT
Sector(s)
Healthcare
Rating
Current Price
$61.21
Price Target
$NaN
Earnings Estimate
Summary

LeMaitre Vascular Inc manufactures and distributes medical devices for the treatment of peripheral vascular disease.

Subscribe to Yahoo Finance Plus Essential for full access
Exclusive reports, detailed company profiles, and best-in-class trade insights to take your portfolio to the next level
Try it Free